EFFECT OF APOMORPHINE ON ADRENAL MEDULLARY CATECHOLAMINE LEVELS
- 12 November 1989
- journal article
- research article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 3 (6) , 665-670
- https://doi.org/10.1111/j.1472-8206.1989.tb00467.x
Abstract
Summary—The effects of the dopamine receptor agonist, apomorphine, on the total catecholamine content of the adrenal medulla were studied in normotensive rats. Apomorphine (3, 15, 30 mg/kg SC) induced a dose‐dependent decrease in catecholamine content of the adrenal gland. The action of apomorphine was suppressed by previous treatment with the non specific dopamine receptor antagonist, haloperidol (9 mg/kg 1P), or the D2 antagonist domperidone (2 mg/kg 1P), but not by the D1 antagonist SCH 23390 (1 mg/kg 1P). The apomorphine‐induced decrease in adrenal catecholamine concentration was suppressed by denervation of the adrenal medulla,i.e.unilateral section of splanchnic fibers performed 5 days before. These results show that, under our experimental conditions, the effect of apomorphine is due to the activation of D2 dopamine receptors probably located on splanchnic nerve endings and suggest the existence of a peripheral D2 dopaminergic system which modulates adrenal medullary catecholamine content.Keywords
This publication has 16 references indexed in Scilit:
- Adrenal Catecholamine Concentration After DomperidoneClinical Neuropharmacology, 1987
- EFFECT OF CLONIDINE ON ADRENAL MEDULLA CATECHOLAMINE LEVELS IN RATSFundamental & Clinical Pharmacology, 1987
- A Dopaminergic Receptor in Adrenal Medulla as a Possible Site of Action for the Droperidol-evoked Hypertensive ResponseAnesthesiology, 1986
- Characterization of a Dopaminergic Receptor that Modulates Adrenomedullary Catecholamine ReleaseJournal of Neurochemistry, 1986
- A dopaminergic receptor modulates catecholamine release from the cat adrenal gland.The Journal of Physiology, 1985
- Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390.Hypertension, 1984
- SCH 23390 is a very potent and selective antagonist at vascular dopamine receptorsEuropean Journal of Pharmacology, 1984
- Selective DA2 versus DA1 antagonist activity of domperidone in the peripheryEuropean Journal of Pharmacology, 1983
- Central dopaminergic regulation of adrenomedullary ornithine decarboxylase activityNeurochemistry International, 1983
- Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activityBiochemical Pharmacology, 1979